Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS

Diane V. Havlir, Michael P. Dubé, J. Allen McCutchan, Donald N. Forthal, Carol A. Kemper, Michael W. Dunne, David M. Parenti, Princy N. Kumar, A. Clinton White, Mallory D. Witt, Stephen D. Nightingale, Kent A. Sepkowitz, Rob Roy MacGregor, Sarah H. Cheeseman, Francesca J. Torriani, Michael T. Zelasky, Fred R. Sattler, Samuel A. Bozzette

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

We compared the efficacy of a 400-mg once-weekly dosage versus a 200-mg daily dosage of fluconazole for the prevention of deep fungal infections in a multicenter, randomized, double-blind trial of 636 human immunodeficiency virus-infected patients to determine if a less intensive fluconazole regimen could prevent these serious but relatively infrequent complications of AIDS. In the intent-to-treat analysis, a deep fungal infection developed in 17 subjects (5.5%) randomly assigned to daily fluconazole treatment and in 24 (7.7%) given weekly fluconazole during 74 weeks of follow-up (risk difference, 2.2%; 95% confidence interval [CI], -1.7% to 6.1%). Thrush occurred twice as frequently in the weekly versus daily fluconazole recipients (hazard ratio, 0.59; 95% CI, 0.40-0.89), and in a subset of patients evaluated, fluconazole resistance was infrequent. Fluconazole administered once weekly is effective in reducing deep fungal infections in patients with AIDS, but this dosage is less effective than the 200-mg-daily dosage in preventing thrush.

Original languageEnglish (US)
Pages (from-to)1369-1375
Number of pages7
JournalClinical Infectious Diseases
Volume27
Issue number6
StatePublished - Dec 1998
Externally publishedYes

Fingerprint

Mycoses
Fluconazole
Acquired Immunodeficiency Syndrome
Oral Candidiasis
Confidence Intervals
HIV

ASJC Scopus subject areas

  • Immunology

Cite this

Havlir, D. V., Dubé, M. P., McCutchan, J. A., Forthal, D. N., Kemper, C. A., Dunne, M. W., ... Bozzette, S. A. (1998). Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. Clinical Infectious Diseases, 27(6), 1369-1375.

Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. / Havlir, Diane V.; Dubé, Michael P.; McCutchan, J. Allen; Forthal, Donald N.; Kemper, Carol A.; Dunne, Michael W.; Parenti, David M.; Kumar, Princy N.; White, A. Clinton; Witt, Mallory D.; Nightingale, Stephen D.; Sepkowitz, Kent A.; MacGregor, Rob Roy; Cheeseman, Sarah H.; Torriani, Francesca J.; Zelasky, Michael T.; Sattler, Fred R.; Bozzette, Samuel A.

In: Clinical Infectious Diseases, Vol. 27, No. 6, 12.1998, p. 1369-1375.

Research output: Contribution to journalArticle

Havlir, DV, Dubé, MP, McCutchan, JA, Forthal, DN, Kemper, CA, Dunne, MW, Parenti, DM, Kumar, PN, White, AC, Witt, MD, Nightingale, SD, Sepkowitz, KA, MacGregor, RR, Cheeseman, SH, Torriani, FJ, Zelasky, MT, Sattler, FR & Bozzette, SA 1998, 'Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS', Clinical Infectious Diseases, vol. 27, no. 6, pp. 1369-1375.
Havlir DV, Dubé MP, McCutchan JA, Forthal DN, Kemper CA, Dunne MW et al. Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. Clinical Infectious Diseases. 1998 Dec;27(6):1369-1375.
Havlir, Diane V. ; Dubé, Michael P. ; McCutchan, J. Allen ; Forthal, Donald N. ; Kemper, Carol A. ; Dunne, Michael W. ; Parenti, David M. ; Kumar, Princy N. ; White, A. Clinton ; Witt, Mallory D. ; Nightingale, Stephen D. ; Sepkowitz, Kent A. ; MacGregor, Rob Roy ; Cheeseman, Sarah H. ; Torriani, Francesca J. ; Zelasky, Michael T. ; Sattler, Fred R. ; Bozzette, Samuel A. / Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS. In: Clinical Infectious Diseases. 1998 ; Vol. 27, No. 6. pp. 1369-1375.
@article{fe4a9555973b4bc8a58a177165f8214e,
title = "Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS",
abstract = "We compared the efficacy of a 400-mg once-weekly dosage versus a 200-mg daily dosage of fluconazole for the prevention of deep fungal infections in a multicenter, randomized, double-blind trial of 636 human immunodeficiency virus-infected patients to determine if a less intensive fluconazole regimen could prevent these serious but relatively infrequent complications of AIDS. In the intent-to-treat analysis, a deep fungal infection developed in 17 subjects (5.5{\%}) randomly assigned to daily fluconazole treatment and in 24 (7.7{\%}) given weekly fluconazole during 74 weeks of follow-up (risk difference, 2.2{\%}; 95{\%} confidence interval [CI], -1.7{\%} to 6.1{\%}). Thrush occurred twice as frequently in the weekly versus daily fluconazole recipients (hazard ratio, 0.59; 95{\%} CI, 0.40-0.89), and in a subset of patients evaluated, fluconazole resistance was infrequent. Fluconazole administered once weekly is effective in reducing deep fungal infections in patients with AIDS, but this dosage is less effective than the 200-mg-daily dosage in preventing thrush.",
author = "Havlir, {Diane V.} and Dub{\'e}, {Michael P.} and McCutchan, {J. Allen} and Forthal, {Donald N.} and Kemper, {Carol A.} and Dunne, {Michael W.} and Parenti, {David M.} and Kumar, {Princy N.} and White, {A. Clinton} and Witt, {Mallory D.} and Nightingale, {Stephen D.} and Sepkowitz, {Kent A.} and MacGregor, {Rob Roy} and Cheeseman, {Sarah H.} and Torriani, {Francesca J.} and Zelasky, {Michael T.} and Sattler, {Fred R.} and Bozzette, {Samuel A.}",
year = "1998",
month = "12",
language = "English (US)",
volume = "27",
pages = "1369--1375",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS

AU - Havlir, Diane V.

AU - Dubé, Michael P.

AU - McCutchan, J. Allen

AU - Forthal, Donald N.

AU - Kemper, Carol A.

AU - Dunne, Michael W.

AU - Parenti, David M.

AU - Kumar, Princy N.

AU - White, A. Clinton

AU - Witt, Mallory D.

AU - Nightingale, Stephen D.

AU - Sepkowitz, Kent A.

AU - MacGregor, Rob Roy

AU - Cheeseman, Sarah H.

AU - Torriani, Francesca J.

AU - Zelasky, Michael T.

AU - Sattler, Fred R.

AU - Bozzette, Samuel A.

PY - 1998/12

Y1 - 1998/12

N2 - We compared the efficacy of a 400-mg once-weekly dosage versus a 200-mg daily dosage of fluconazole for the prevention of deep fungal infections in a multicenter, randomized, double-blind trial of 636 human immunodeficiency virus-infected patients to determine if a less intensive fluconazole regimen could prevent these serious but relatively infrequent complications of AIDS. In the intent-to-treat analysis, a deep fungal infection developed in 17 subjects (5.5%) randomly assigned to daily fluconazole treatment and in 24 (7.7%) given weekly fluconazole during 74 weeks of follow-up (risk difference, 2.2%; 95% confidence interval [CI], -1.7% to 6.1%). Thrush occurred twice as frequently in the weekly versus daily fluconazole recipients (hazard ratio, 0.59; 95% CI, 0.40-0.89), and in a subset of patients evaluated, fluconazole resistance was infrequent. Fluconazole administered once weekly is effective in reducing deep fungal infections in patients with AIDS, but this dosage is less effective than the 200-mg-daily dosage in preventing thrush.

AB - We compared the efficacy of a 400-mg once-weekly dosage versus a 200-mg daily dosage of fluconazole for the prevention of deep fungal infections in a multicenter, randomized, double-blind trial of 636 human immunodeficiency virus-infected patients to determine if a less intensive fluconazole regimen could prevent these serious but relatively infrequent complications of AIDS. In the intent-to-treat analysis, a deep fungal infection developed in 17 subjects (5.5%) randomly assigned to daily fluconazole treatment and in 24 (7.7%) given weekly fluconazole during 74 weeks of follow-up (risk difference, 2.2%; 95% confidence interval [CI], -1.7% to 6.1%). Thrush occurred twice as frequently in the weekly versus daily fluconazole recipients (hazard ratio, 0.59; 95% CI, 0.40-0.89), and in a subset of patients evaluated, fluconazole resistance was infrequent. Fluconazole administered once weekly is effective in reducing deep fungal infections in patients with AIDS, but this dosage is less effective than the 200-mg-daily dosage in preventing thrush.

UR - http://www.scopus.com/inward/record.url?scp=0032466799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032466799&partnerID=8YFLogxK

M3 - Article

VL - 27

SP - 1369

EP - 1375

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 6

ER -